Mie K. Eickhoff

Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial

Nete Tofte, Morten Lindhardt, Katarina Adamova et al. · The Lancet Diabetes & Endocrinology · 2020 · 247 citations · Full text

Urology, Renal Disease, Renal Function +8

Effects of Dapagliflozin on Volume Status When Added to Renin–Angiotensin System Inhibitors

Mie K. Eickhoff, Claire C. J. Dekkers, Bart J. Kramers et al. · Journal of Clinical Medicine · 2019 · 92 citations · Full text

Predictors of Graft Failure and Death in Elderly Kidney Transplant Recipients

Arman Faravardeh, Mie K. Eickhoff, Scott Jackson et al. · Transplantation · 2013 · 88 citations

Effect of dapagliflozin on cardiac function in people with type 2 diabetes and albuminuria – A double blind randomized placebo-controlled crossover trial

Mie K. Eickhoff, Flemming Javier Olsen, Marie Frimodt‐Møller et al. · Journal of Diabetes and its Complications · 2020 · 39 citations

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +8

Urinary tubular biomarkers as predictors of kidney function decline, cardiovascular events and mortality in microalbuminuric type 2 diabetic patients

Viktor Rotbain Curovic, Tine W. Hansen, Mie K. Eickhoff et al. · Acta Diabetologica · 2018 · 33 citations

Hypertension, Urology, Renal Disease +11